Europe's bio-nematicides market was valued at USD 53.68 million in 2023 and is anticipated to reach USD 63.18 million in 2024 from USD 232.70 million by 2032, growing at a CAGR of 17.70% from 2024 to 2032.
Bionematicides, for the most part, contain fungal or bacterial spores and inert material. Spores incorporated into the bionematicide germinate and paralyze the living being in contact with it. It is accessible in fluid and powder form. The upsides of bionematicides incorporate no resistance advancement, no resurgence and no residues.
Europe is expected to lead the bionematicides showcase during the forecast period. Factors such as integrated pest management methods and an increased selection of agriculture microbials are driving interest in bionematicides in this region. In addition, countries like Spain and France have agriculture as their significant part, which impacts the GDP of the nation and is another variable that drives the market for bionematicides in Europe.
Some of the major companies dominating the bio nematicides market by their products and services include Bayer CropScience AG, Monsanto Company, BASF SE, Certis USA L.L.C, Syngenta AG, FMC Corporation, Dow AgroSciences LLC, Valent BioSciences Corporation and Marrone Bio Innovations, Inc.,
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region